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Fig. 1 Clinical appearance at the first visit (a) and the later occurence of the bulous disease (b).
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Dear Editor
Does Drug-induced Hypersensitivity Syn-
drome Elicit Bullous Pemphigoid?
A 68-year-old Japanese woman presented to our
hospital for disseminated erythema on the whole
body, lymphadenitis and high fever on 10 August
2003 (Fig. 1a). The erythema developed with a sud-
den onset after taking minocycline hydrochloride for
pharyngitis and 38-degree fever on 6 August 2003
( day 0 ) . She had taken carbamazepine and zon-
isamide for one year to control trigeminal neuralgia.
Histopathological examination demonstrated perivas-
cular dermatitis, and infiltration cells mainly con-
sisted of eosinophils and lymphocytes in the upper
dermis. She was given a diagnosis of drug eruption,
and all the medication was stopped (day 4). However,
erythema continued to develop, and we administered
60mgday of oral prednisolone (day 8), after which
the fever and erythema gradually ameliorated. Labo-
ratory data showed leukocytosis (20.14 × 109L), hy-
pereosinophilia (23%), atypical lymphocytes (4%), ele-
vated γ-glutamyltranspeptidase ( 385UL) and ele-
vated liver enzymes (aspartate transaminase 19UL,
alanine aminotransferase 61UL). Thereafter, titer for
human herpes virus 6 (HHV-6) IgG increased from ×
10 (day 8) to ×1280 (day 25). Collectively, a diagnosis
of drug-induced hypersensitivity syndrome (DIHS)
was established. We could not perform patch testing,
and results of drug-induced lymphocyte stimulation
tests for carbamazepine, zonisamide and minocycline
hydrochloride were negative. It remained unclear
which drug elicited the eruption. While tapering oral
prednisolone, we started cyclosporine (3mgkg) be-
cause we found slight recurrence of erythema (day
58), and we finally reduced oral prednisolone to 20
mgday, with slight erythema remaining (day 68) .
However, 9 days later ( day 77 ) , itchy edematous
erythema and tense bullae developed on the trunk
and extremities, and there was no relationship be-
tween the distribution of the DIHS eruptions and the
new eruptions (Fig. 1b). Biopsy specimens revealed
subepidermal blisters with eosinophil and lympho-
cyte infiltration. Direct and indirect immunofluores-
cence showed lesional and circulating IgG autoanti-
bodies at the basement membrane (Fig. 2). The labo-
ratory data demonstrated hypereosinophilia (36.6%)
and high index of anti-BP180 ( 2780 ) antibody by
ELISA (day 92). Anti-nuclear antibody was negative.
Thus, we diagnosed bullous pemphigoid (BP). De-
spite of the combination therapy with oral predniso-
lone (50mgday), cyclosporine (3―5mgkg), azathio-
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Fig. 2 Positive deposition of IgG at the basement mem
brane zone on direct immunofluorescence (DIF) studies.
Fig. 3 Clinical and laboratory course of DIHS (a) and BP (b). HHV-6, human herpesvirus 6; PSL, prednisolone; CyA, cyclo-
sporine; CYC, cyclophosphamide; DFPP. Double filtration plasmapheresis; AZP, azathioprine; MMF, mycophenolate mofetil.
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prine (100mgday) , cyclophosphamide pulse (500
mgday) , or double filtration plasmapheresis, the
eruptions were recalcitrant. Finally a remission was
achieved by starting mycophenolate mofetil (3gday)
and the titer of anti-BP180 antibody began to de-
crease markedly(Fig. 3).
To the best of our knowledge, this is the first re-
port of BP developing consecutively after DIHS. The
pathological or immunological linkage as to whether
BP occurred incidentally after DIHS or was induced
by DIHS remains unclear. However, Kano et al. re-
ported a case of sclerodermoid graft-versus-host
disease-like lesions occurring after DIHS.1 They sug-
gested that the autoimmune manifestations observed
in patients with chronic GVHD could also be seen in
patients with DIHS in view of clinical similarity be-
tween GVHD and DIHS. Although a recent report
showed that a decrease in immunoglobulin levels and
B-cell counts can be associated with HHV-6 reactiva-
tion and the subsequent onset of DIHS,2 our present
case suggests that this disease may involve or evolve
into other immunological events including autoimmu-
nity.
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